Johns Hopkins Diabetes Guide
Insulins (Basal): Intermediate- and Long-acting
INDICATIONS
FDA
FDA
- Type 1 diabetes mellitus (DM1)
- Type 2 diabetes mellitus (DM2)
- Gestational Diabetes
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 3, 2018
Citation
Béliard Veillard, Régine, and Stacy E Dalpoas. "Insulins (Basal): Intermediate- and Long-acting." Johns Hopkins Diabetes Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547074/8/Insulins__Basal_:_Intermediate__and_Long_acting.
Béliard Veillard , Dalpoas SE. Insulins (Basal): Intermediate- and Long-acting. Johns Hopkins Diabetes Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547074/8/Insulins__Basal_:_Intermediate__and_Long_acting. Accessed December 6, 2023.
Béliard Veillard, ., & Dalpoas, S. E. (2018). Insulins (Basal): Intermediate- and Long-acting. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547074/8/Insulins__Basal_:_Intermediate__and_Long_acting
Béliard Veillard , Dalpoas SE. Insulins (Basal): Intermediate- and Long-acting [Internet]. In: Johns Hopkins Diabetes Guide. ; 2018. [cited 2023 December 06]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547074/8/Insulins__Basal_:_Intermediate__and_Long_acting.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulins (Basal): Intermediate- and Long-acting
ID - 547074
A1 - Béliard Veillard, Régine,Pharm.D.
AU - Dalpoas,Stacy,Pharm.D.
Y1 - 2018/12/03/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547074/8/Insulins__Basal_:_Intermediate__and_Long_acting
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
